OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Nikolaus Schultz, Mrinal M. Gounder et al.|JCO Precision Oncology|2017Cited by 2.7k
Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependenceChengcheng Yang, Sarat Chandarlapaty|Oncogene|2016Cited by 430
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Kornélia Polyák, Lin Liu et al.|Nature Genetics|2015Cited by 166
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer functionKinisha Gala, Sarat Chandarlapaty|Oncogene|2018Cited by 149
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathwayAlison Smith, Sarat Chandarlapaty|Nature Communications|2021Cited by 86